Cardiovascular disease remains one of the UK’s biggest health challenges, but new technologies are transforming care. Candesic’s Dr Kristoffer Kenttä, senior engagement manager and cardiologist, and Dr Leonid Shapiro, managing partner, explore why investor interest is growing in this high-cost, high-impact sector Cardiovascular diseases (CVD) is placing mounting pressure on the UK’s healthcare system with costs…
Membership Required
You must be a HM Subscriber to view this content.
Already have an account? Sign In
©2026 All rights reserved LaingBuisson
